home All News open_in_new Full Article

Experimental women's cancer drug boosts survival rates in notable study

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer. Researchers discuss the findings.


today 26 h. ago attach_file Events

attach_file Science
attach_file Events
attach_file Politics
attach_file Events
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Economics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics


ID: 3079881070
Add Watch Country

arrow_drop_down